UnitedHealth Deal Boosts Genomic Health
Shares of Genomic Health(GHDX Quote) jumped 15% after the company said insurer UnitedHealth(UNH Quote) will cover the use its Oncotype DX tests to detect the risk of recurrence in breast cancer patients.
The tests are used to measure the likelihood of breast cancer recurrence in patients who've already been diagnosed, and to predict the possible benefit a patient might have from chemotherapy, Genomic Health said. The stock was gaining $3.19 to $23.87.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
